SFTA1P and cancer: These findings reveal new insights into the regulation and function of the lncRNAs that are transcriptionally regulated by YAP/TAZ and specifically highlight SFTA1P as a potential therapeutic target for the treatment of YAP/TAZ-associated cancers.